These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37246811)

  • 1. Targeting protein-protein interactions with low molecular weight and short peptide modulators: insights on disease pathways and starting points for drug discovery.
    Trisciuzzi D; Villoutreix BO; Siragusa L; Baroni M; Cruciani G; Nicolotti O
    Expert Opin Drug Discov; 2023 Jul; 18(7):737-752. PubMed ID: 37246811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational approaches for the design of modulators targeting protein-protein interactions.
    Rehman AU; Khurshid B; Ali Y; Rasheed S; Wadood A; Ng HL; Chen HF; Wei Z; Luo R; Zhang J
    Expert Opin Drug Discov; 2023 Mar; 18(3):315-333. PubMed ID: 36715303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery.
    Ni D; Lu S; Zhang J
    Med Res Rev; 2019 Nov; 39(6):2314-2342. PubMed ID: 30957264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment-based drug discovery supports drugging 'undruggable' protein-protein interactions.
    Wang ZZ; Shi XX; Huang GY; Hao GF; Yang GF
    Trends Biochem Sci; 2023 Jun; 48(6):539-552. PubMed ID: 36841635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Protein-Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches.
    Monti A; Vitagliano L; Caporale A; Ruvo M; Doti N
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.
    Ran X; Gestwicki JE
    Curr Opin Chem Biol; 2018 Jun; 44():75-86. PubMed ID: 29908451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focusing on shared subpockets - new developments in fragment-based drug discovery.
    Abdelraheem EM; Camacho CJ; Dömling A
    Expert Opin Drug Discov; 2015; 10(11):1179-87. PubMed ID: 26296101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric Modulators of Protein-Protein Interactions (PPIs).
    Ni D; Liu N; Sheng C
    Adv Exp Med Biol; 2019; 1163():313-334. PubMed ID: 31707709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico design of low molecular weight protein-protein interaction inhibitors: Overall concept and recent advances.
    Kuenemann MA; Sperandio O; Labbé CM; Lagorce D; Miteva MA; Villoutreix BO
    Prog Biophys Mol Biol; 2015 Oct; 119(1):20-32. PubMed ID: 25748546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Allosteric Modulators of Voltage-Gated Na
    Dvorak NM; Wadsworth PA; Wang P; Zhou J; Laezza F
    Curr Top Med Chem; 2021; 21(10):841-848. PubMed ID: 34036922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulators of 14-3-3 Protein-Protein Interactions.
    Stevers LM; Sijbesma E; Botta M; MacKintosh C; Obsil T; Landrieu I; Cau Y; Wilson AJ; Karawajczyk A; Eickhoff J; Davis J; Hann M; O'Mahony G; Doveston RG; Brunsveld L; Ottmann C
    J Med Chem; 2018 May; 61(9):3755-3778. PubMed ID: 28968506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational methods-guided design of modulators targeting protein-protein interactions (PPIs).
    Qiu Y; Li X; He X; Pu J; Zhang J; Lu S
    Eur J Med Chem; 2020 Dec; 207():112764. PubMed ID: 32871340
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Hashemi ZS; Zarei M; Fath MK; Ganji M; Farahani MS; Afsharnouri F; Pourzardosht N; Khalesi B; Jahangiri A; Rahbar MR; Khalili S
    Front Mol Biosci; 2021; 8():669431. PubMed ID: 33996914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How can artificial intelligence be used for peptidomics?
    Perpetuo L; Klein J; Ferreira R; Guedes S; Amado F; Leite-Moreira A; Silva AMS; Thongboonkerd V; Vitorino R
    Expert Rev Proteomics; 2021 Jul; 18(7):527-556. PubMed ID: 34343059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating protein-protein interactions: the potential of peptides.
    Nevola L; Giralt E
    Chem Commun (Camb); 2015 Feb; 51(16):3302-15. PubMed ID: 25578807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of protein-protein interactions in drug discovery.
    Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
    Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of physicochemical properties of protein-protein interaction modulators suggests stronger alignment with the "rule of five".
    Truong J; George A; Holien JK
    RSC Med Chem; 2021 Oct; 12(10):1731-1749. PubMed ID: 34778774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-Protein Interaction Modulators for Epigenetic Therapies.
    Díaz-Eufracio BI; Naveja JJ; Medina-Franco JL
    Adv Protein Chem Struct Biol; 2018; 110():65-84. PubMed ID: 29413000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.